Credit: Eriko Kage-Nakadai, Osaka City University
Metolazone, a drug used to treat hypertension, activates a mitochondrial stress response that prolongs lifespan in the roundworm Caenorhabditis elegans
A stress response of mitochondria, the part of our cells that produce energy to power bodily functions, is important to a longer life. A team of scientists from Osaka City University, Japan, searched through a chemical “library” of existing drugs to find one that can activate this stress response in the worm Caenorhabditis elegans. They found that an anti-hypertension drug called metolazone prolongs C. elegans lifespan, marking the first step in developing anti-aging pharmaceuticals.
Since time immemorial, people have been fascinated by ways to stop aging. Nearly every culture has stories to tell about people who lived for thousands of years, showing that extending lifespan has always been one a deep desire across humanity. While modern medicine does not strive to find the fountain of youth, keen interest in promoting longevity has prompted research into the mechanisms of aging and the possibility of anti-aging drugs. Researchers now know that mitochondria play an important role in aging. Specifically, when mitochondria are harmed in some way and their function is impaired, a process called mitochondrial unfolded protein response (UPRmt) occurs that repairs mitochondria and benefits cell survival. Therefore, some scientists think it is possible to increase lifespan by identifying drugs that activate UPRmt.
Dr. Eriko Kage-Nakadai and her colleagues from Osaka City University in Japan are one of the many research teams fascinated by aging research. As Dr. Kage-Nakadai explains, “Even though aging is not a disease, drugs may slow down aging and mitigate or prevent its negative effects on our health.” Current research shows promising signs. Experiments with Caenorhabditis elegans—a worm commonly used in biological research as a model—have found several compounds that increase the worm’s lifespan by triggering UPRmt.
Against the backdrop of these previous studies, this team, in their new study published in Biogerontology, screened about 3,000 drugs in worms that are engineered to glow if drug treatment activates hsp-6, a gene that is highly expressed when UPRmt occurs. It is interesting to note that of these 3000 drugs, 1300 were off-patent drugs approved by the USFDA, EMA, and other agencies, and the remaining 1700 were unapproved bioactive ones.
Through this method, Dr. Kage-Nakadai’s team identified metolazone, a drug used to treat heart failure and high blood pressure. They then tested the drug on C. elegans and found that it increased wild-type worm lifespan. Additionally, they found that metolazone did not extend lifespans in worms in whom the genes atfs-1, ubl-5, and nkcc-1 were mutated (non-working). The former two genes are known to be essential for UPRmt function, suggesting that metolazone is acting on the UPRmt pathway. The third gene, nkcc-1, “encodes” a protein that is part of a protein family targeted by metolazone in its usual function as an anti-hypertension drug. The fact that metolazone did not increase the lifespans of nkcc-1 mutated C. elegans suggests that the drug may need to block the nkcc-1 protein to activate the UPRmt pathway. Furthermore, metolazone “induced” hsp-6 (Hspa9 in humans) expression in HeLa cells (a human cell line commonly used in biological research), suggesting that the drug’s UPRmt-related effects possibly span multiple species.
When asked about the broader significance of her work, Dr. Kage-Nakadai comments, “What is particularly exciting is that we tested already available approved drugs here, and we have revealed the potential of repurposing existing drugs for aging control. Worms always give us many hints.”
As the researchers state, this work is just the start, but it opens up a new road to a future of anti-aging drugs. Perhaps a future where humans live longer than the expected 120 years is one step closer to becoming a reality.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Increasing lifespan
- Fine increased to $1.8M for yacht grounding at Honolua; includes cultural resource damages and community distress
The Board of Land and Natural Resources increased a fine against the owners and operator of the luxury yacht, Nakoa, to $1,818,85.97 on Friday, to account for biological and cultural damages, as well ...
- Conestoga Valley School District approves contract with 15% salary increase for starting teachers
The Conestoga Valley School District in Lancaster County has approved a teachers' contract that includes a 15% salary increase for starting teachers over the life of the contract. In the first year of ...
- Life Insurance with Preexisting Conditions
Getting life insurance with a pre-existing condition can be difficult. Understand what insurers look for and how to find the best policy for your needs.
- Another View: Decline in American life expectancy harms more than our health
American life expectancy started dropping even before the pandemic. It’s a critical barometer of our nation’s health and a sign that all is not well in the U.S. Much of the increase in ...
- Scientists Reveal Simple Trick for a Longer Life
Regularly climbing the stairs was associated with a 24 percent reduced risk of all-cause mortality and a 39 percent lower likelihood of dying from cardiovascular disease. It was also associated with a ...
Go deeper with Google Headlines on:
Increasing lifespan
[google_news title=”” keyword=”increasing lifespan” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Anti-aging pharmaceuticals
- 'The lives we have changed with our skincare products is a pinch me moment'
Lucy Goff founded leading WellTech brand Lyma after recovering from septicemia following the birth of her first child.
- 13 Celebrities Who Have Spoken Out About Taking GLP-1s
Explore how GLP-1 drugs like Ozempic and Mounjaro are reshaping the conversation around weight loss, with insights from celebrities and medical experts.
- Bazi Bushen Capsule Became the Representative Drug of Anti-aging Chinese Medicine
On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held in Shijiazhuang. Yiling Pharmaceutical's Bazi Bushen ...
- Unlocking Opportunities: Mushroom Fermenter Market Thrives Across Industries
The global mushroom fermenter market is set to witness growth rate of 5.6% over the forecast period (2022-2032), totaling around US$ 2.4 Bn by 2032. Mushroom fermenter has a wider applicability in ...
- A cheap drug may slow down aging. A study will determine if it works
Studies suggest people who take metformin for diabetes may be at lower risk for cancer, heart disease and dementia. Now researchers aim to test if it prevents age-related diseases in healthy people.
Go deeper with Google Headlines on:
Anti-aging pharmaceuticals
[google_news title=”” keyword=”anti-aging pharmaceuticals” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]